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Introduction
In 2009, when it appeared likely that binge eating disorder (BED) would be recommended
for inclusion as an official diagnosis in the Fifth Edition of the Diagnostic and Statistical
Manual of Mental Disorders (DSM-5), a number of researchers believed that it was
important to initiate planning for the next generation of research. At the time, it had been
established that BED is associated with significant impairment. The robust relationship
between BED and obesity prompted researchers in many fields such as eating disorders,
addictions, pediatrics, cardiology, and health disparities, to investigate disinhibited eating.
Although a large body of research was generated, the researchers in these varied fields were
working largely independently.
To enhance communication and collaboration across fields, we received a grant from the
National Institute of Mental Health to conduct a workshop in April, 2012 entitled, “Binge
Eating Disorder: The Next Generation of Research”. Investigators, representatives from the
National Institutes of Health (NIH), clinicians, and lay advocates in the fields of eating
disorders, obesity, and addictions were in attendance. Participants are listed in Table 1 and
presentation slides are in Appendix 1. The goal of the workshop was to promote lively and
forward-thinking discussions to outline future steps for BED research. This document
represents a summary of the proceedings from the workshop.
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Why BED will be in DSM-5
State of Current Knowledge
In 1994, BED was introduced into the DSM-IV as a provisional set of criteria describing a
syndrome characterized by recurrent episodes of binge eating in the absence of the
inappropriate compensatory behaviors that define bulimia nervosa. Its inclusion paved the
way for a plethora of studies exploring the epidemiology, etiology, clinical presentation,
course and treatment of BED. One of the goals of the DSM-5 Eating Disorders Task Force
was to determine, based on these data, whether BED should remain in the DSM and, if so,
whether the criteria should be preserved or modified. In doing so, the Task Force considered
three guiding principles. First, the DSM should be of maximum clinical utility. Therefore,
changes should improve clinicians’ ability to help clients encountered in their daily practice.
Second, changes should be based on scientific evidence. Third, care should be taken to
preserve continuity from DSM-IV to DSM-5 without conflicting with the former two
principles.
Presently, the largest obstacle to optimal clinical utility of the DSM-IV is that a majority of
individuals who seek treatment for an eating disorder do not meet diagnostic criteria for
anorexia nervosa or bulimia nervosa. Rather, their clinical symptoms best fit a diagnosis of
eating disorder not otherwise specified (EDNOS). As a result, EDNOS includes a
heterogeneous group of symptom constellations and represents the largest eating disorder
category. This limits the clinical utility of the diagnosis of EDNOS in that the prognosis
implied by, or the treatments effective for, one form of EDNOS (e.g., subthreshold anorexia
nervosa) may differ quite markedly from another (e.g., BED). Moreover, although EDNOS
is supposed to represent a full-syndrome psychiatric disorder, some presentations included
under EDNOS are subthreshold variants of anorexia nervosa or bulimia nervosa and thus
may contribute to the sense that EDNOS conditions are “lesser” problems. Indeed, some
insurance companies will not pay for services associated with treating EDNOS.
Several factors led to BED being separated out from EDNOS and becoming a candidate for
an independent diagnosis. First, individuals with a diagnosis of BED comprise a large
percentage of those receiving an EDNOS diagnosis in clinical settings. Second, BED criteria
can be reliably applied to clinical cases. Third, individuals with BED differ on meaningful
clinical indicators from individuals without BED and from individuals with conditions that
share some clinical features such as bulimia nervosa or obesity. Fourth, effective treatments
are available for BED. On the basis of these four observations, including BED as an official
diagnosis in DSM-5 is in concert with the first two guiding principles for DSM-5. Its
inclusion in DSM-5 as a distinct diagnostic entity would reduce the large EDNOS category
without creating a substantial number of new psychiatric cases. With regard to the third
principle (i.e., continuity between DSM-IV and 5), the Task Force suggested that only the
frequency criterion (D) be modified such that binge eating occurs, on average, at least once a
week for 3 months. This minor modification represents a change from BED in DSM-IV, but
makes the binge eating frequency criterion BED consistent with the binge eating frequency
criterion of bulimia nervosa.
Future Directions of the Task Force
Along with the recommendation to “upgrade” BED to an official diagnosis in the DSM-5,
the Eating Disorders Task Force suggested areas for future research. Because the following
sections will describe future directions in more detail, only three are briefly mentioned
herewith. The next generation of research should consider developmental aspects of BED.
For example, defining and measuring binge eating poses a challenge in children since the
overeating criterion of a binge episode may be limited by parental restrictions and evaluating
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a large amount of food may be beyond children’s cognitive capacities. In line with this
example, another proposed area for research involves elucidating whether loss of control is a
more critical component than overeating in adult binge eating episodes and whether both
elements are necessary. Lastly, further exploration is required to determine whether the BED
duration criterion of 3 months is unduly restrictive.
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Lifespan: Risk Factors
State of Current Knowledge
BED typically manifests in adolescence or adulthood. However, retrospective data from
adult samples and prospective studies in young children suggest that risk for BED may be
present well before the manifestation of the disorder or even symptoms of the disorder. For
example adult studies show that the heritability of BED is approximately 50%. Moreover,
retrospective studies of adults have found self-reported childhood risk factors for BED.
Specifically, child obesity, maltreatment including teasing and bullying, as well as perceived
stress are risk factors for the disorder.
Although development of the full syndrome of BED is uncommon in childhood, episodes of
loss of control eating (an inability to stop eating or control the amount or type of food
consumed) are not infrequently reported by pre-adolescent youth. Paralleling adult BED,
children who report loss of control eating have excess adiposity and endorse greater eating
disordered attitudes and depressive symptoms than children without such episodes. Loss of
control eating prior to adolescence appears to confer risk for development of excess weight
and fat gain, metabolic syndrome components and most notably, partial or full-syndrome
BED. Risk factors for loss of control eating in childhood may include genetic factors (for
example, pediatric loss of control eating is associated with at least one candidate gene, FTO
rs9939609 obesity risk alleles, after accounting for the contribution of body weight), and
psychosocial factors (such as parental under-involvement and critical comments).
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An important area for investigation should be identifying early risk factors for BED and loss
of control eating in animal and human models. Proposed prospective designs should involve
elucidating the biological, psychological, and social factors influencing the entire family,
including examining relevant variables related to mothers and fathers prior to conception
and during pregnancy (e.g., parental weight history, paternal age, maternal nutrition during
pregnancy). Importantly, the interaction among and between physical and environment
variables should be considered. Research focused on developing early interventions is an
important next step for BED. Once risk profiles for BED are identified, potential areas for
early intervention can be pursued such as perinatal identification; training programs for
parents of young children; and family-based interventions during middle childhood and
early adolescence.
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State of Current Knowledge
There are two main levels of assessment that should be considered. The first is at the level of
the syndrome and involves, for example, diagnostic criteria in the DSM. The second is at the
level of the components of the syndrome, and involves assessment of features such as
consumption of a large amount of food, sense of loss of control over eating, behavioral
indicators of loss of control, and distress about the eating behavior.
Current methods of assessment can be divided into those using self-report (which includes
interviews, diaries, and ecological momentary assessment), and direct observation, such as
laboratory meals. The reliability of assessments has been examined at the syndromal level
for diagnosis, and also at the component level for amount of food consumed and loss of
control. Generally, there is acceptable reliability within a method, but the cross-method
reliability (e.g., diary vs. laboratory meals for food consumption during binges) is less clear.
Each method of assessment has advantages and disadvantages. Interviews allow structured
questions and the ability to probe, but are time consuming and rely on skill of the
interviewer and the reporting ability of the interviewee. Self-report is time efficient, but
relies on the interviewee’s understanding of questions and accuracy. Ecological momentary
assessment obtains data in real time, but relies on the participant’s cooperation and ability to
report accurately. Laboratory meals obtain objective data regarding eating, but the non-
naturalistic setting influences behavior and psychological state.
In summary, the diagnosis of BED can be reliably established by interview and self-report,
with interview being the consensus method of choice. Different methods of assessment have
different advantages and disadvantages, and agreement across methods is variable.
Future Directions
A priority for future research is cross-method validation; for example, comparing the results
of different methods used to assess the same construct. Also, there should be more study of
the relationship between components; for example, the relationship of loss of control to
amount consumed. Furthermore, the contributions of the various components of the
syndrome to the overall validity of the syndrome should be investigated; for example,
examining the relative contribution to diagnostic validity of loss of control over eating vs.
amount of food consumed. Finally, objective measures should be developed to help assess
components of the syndrome; for example, using biomarkers of stress in the assessment of
distress.
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State of Current Knowledge
Individuals with BED experience significant impairment in psychosocial functioning.
Compared with obese adults without BED, obese adults with the disorder report lower
quality of life in the domains of physical health conditions and mobility, emotional well-
being, work, sexual life, public distress, and self-esteem. Individuals with BED also
experience impaired functioning in both their social life and at home. Moreover, BED is
associated with higher levels of disability and health problems. With regard to comorbid
diagnoses, similar percentages of adults with BED experience Axis I psychiatric disorders,
such as major depressive disorder, anxiety disorders, and substance use disorders as
individuals with anorexia nervosa and bulimia nervosa. BED is also commonly comorbid
with impulse control disorders such as ADHD. The most common comorbid Axis II
(personality) disorders in individuals with BED are avoidant, borderline, and obsessive-
compulsive personality disorders. Despite consistent findings from cross-sectional studies
that BED is associated with the co-occurrence of a wide range of disorders, the potential
impact of the presence of any of these comorbid disorders on the course or outcome of BED
is unclear.
Future Directions
Given the dearth of naturalistic prospective studies on the outcome of BED, an essential next
research step involves examining the psychiatric consequences, quality of life, and
psychosocial functioning of the individuals with the disorder. Furthermore, since BED often
presents with various comorbid disorders, the etiologic, pathophysiologic, and treatment
implications of psychopathology-related heterogeneity in BED should be investigated.
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following treatment. J Consult Clin Psychol. 2000; 68:641–649. [PubMed: 10965639]
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Research Domain Criteria (RDoC)
State of Current Knowledge
At present, psychiatric nosology is based on clinical observation and symptom reports, as
exemplified by the Diagnostic and Statistical Manual of the American Psychiatric
Association and the International Classification of Diseases. However, new data from
neuroscience research on genetic factors, brain circuit abnormalities, and behavioral factors
do not map well onto current diagnoses. Thus, the Research Domain Criteria (RDoC) project
was initiated to implement the NIMH strategic goal to “develop for research purposes, new
ways of classifying mental disorders based on dimensions of observable behavior and
neurobiological measures.” There are a number of guiding principles of RDoC. First, RDoC
is conceived as a dimensional system, spanning from normal to abnormal. RDoC is agnostic
with regard to current diagnostic categories. Thus, the approach involves identifying
relevant neurobiological dimensions and linking them to salient clinical phenomena rather
than starting with current DSM diagnostic categories. In addition, RDoC proposes the use of
multiple units of analysis to assess the validity of the dimensional constructs. Specifically,
genes, molecules, cells, circuits, physiology, behavior, and self-reports may be utilized to
elucidate the psychopathological phenomena. Thus, RDoC provides a novel heuristic to
guide the examination of salient domains and constructs that underlie different eating
disorder diagnoses as well as other forms of psychopathology. This approach has promise to
promote understanding of the heterogeneity within diagnostic categories (e.g., BED) and
similarities in phenotypic expression across disorders.
Future Directions
Although RDoC is a work in progress, this framework may prove useful in elucidating the
heterogeneity in symptom presentations within BED and the other eating disorders. RDoC
also may hold promise for understanding phenotypic similarities and distinctions among
eating disorders and other diagnoses in which binge eating is common (e.g., bipolar disorder
and attention deficit hyperactivity disorder).
Key References
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Relationship of Addictions to Obesity
State of Current Knowledge
Similar brain mechanisms may underlie drug addiction and obesity. Brain signals that
control drug consumption via the reward circuit and dopaminergic neurotransmission also
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control food consumption. Individuals with cocaine and alcohol abuse show blunted
dopamine increase to stimulants, and individuals with high BMI also show decreased
response to food reward compared with individuals with low BMI. Dopamine D2 receptors
are decreased in addiction and also in obese individuals. These results and similar studies,
including pre-clinical studies, suggest common processes in drug addiction and obesity.
A systems model of addiction and of obesity has been proposed. In the healthy individual,
the salience of the rewarding substance (drug or food) is normal, and there is normal self-
regulation, which leads to appropriate inhibitory control over the drive to consume. In
contrast, in an individual whose system is dysregulated, the salience is enhanced (augmented
by amplified memory or conditioning) and the self-regulation is weaker, leading to less
control over the drive to consume.
Future Directions
The main potential implication of this body of work for BED is that individuals with BED
display not only appetite and weight dysregulation but also other forms of dysregulated
behavior, including addictions. Therefore, BED, especially when coupled with overweight
or obesity, may represent a form of disordered eating and weight dysregulation driven and
maintained by similar pathophysiological abnormalities associated with addictions. Further
studies should examine the extent to which BED shares neurobiological abnormalities with
addictions and whether these abnormalities are more likely to be present in individuals who
are obese and have BED than in obese individuals who do not binge eat (see also future
directions for addictive processes below).
Key References
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Addictive Processes
State of Current Knowledge
Neuropsychological systems associated with addictions-related processes include the
impulsive system and the executive system. The impulsive system is embodied in the limbic
and para-limbic brain regions, functions in biological reinforcement, and is most often
hyperactive in disease states. The executive system is embodied in the prefrontal cortex,
functions in valuation of the future, planning, and remembering of events, and is most often
hypoactive in disease states.
Addiction-related processes are relevant to BED in that they may be involved in food
reinforcement and loss of control of eating. In terms of food reinforcement, imaging studies
have shown that dopamine release is associated with BED (using positron emission
tomography), and enhanced reward sensitivity associated with greater activation of the
orbitofrontal cortex in BED. Turning to loss of control, studies of executive function,
decision-making, or related measures in BED have found impairment in BED compared
with non-obese individuals without BED (in all studies), and also compared with individuals
with obesity who do not have BED (in most studies).
Future Directions
Future directions for research include examination of the full range of impulsive and
executive function categories in BED; comparison of BED with addictive disorders, other
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eating disorders, and obesity; and investigation of the extent to which BED relates to an
underlying addictive process based on neural circuit abnormalities or other endophenotypic
abnormalities.
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Obesity: The relationship of Obesity to Ultra-Processed Energy-Dense
Foods
State of Current Knowledge
The current food environment is replete with highly energy-dense, ultra-processed foods
served in enormous portion sizes. These food types may promote obesity and associated
health comorbidities. Since humans acutely regulate food intake by volume, more so than by
calorie content, chronic consumption of highly energy dense foods may increase risk for
excess body weight by overeating.
Ultra-processed foods are also low in nutrient and fiber content. Animal data suggest that
low intake of micronutrient and phytochemicals may increase energy intake and are
associated with increased adiposity. Fiber has been shown to have a modest positive impact
on body weight and a major beneficial effect for reducing cardiovascular disease and
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diabetes. Moreover, a high fiber diet may potentially protect against cancer and reduce
mortality.
In addition, ultra-processed foods are often comprised of solid fats, including saturated and
trans-fats. Unlike liquid fats that protect against cardiovascular disease, solid fats promote
these diseases. Solid fats may also have an impact on body weight. Indeed, trans-fats
increase abdominal obesity and insulin resistance in monkeys, while humans fed
polyunsaturated experience improved adiposity and adiponectin levels.
Furthermore, the high-intensity flavoring of ultra-processed foods may promote obesity.
Sweet, salty and fatty flavors of these foods are enhanced through chemical manipulation.
High-intensity flavoring may override endogenous satiety mechanisms and cause naturally
sweet foods, such as fruit, to taste bland and unsweet foods, such as vegetables, to taste
unpalatable.
Also, ultra-processed foods impact the rate of nutrient digestion and absorption. In contrast
to unprocessed foods that are digested slowly and elicit high levels of satiety, highly
processed foods are typically digested quickly, likely causing overconsumption. This
phenomenon can be described by the glycemic index, a measure of how blood glucose level
changes in the postprandial after consumption of carbohydrate-containing foods. A high
glycemic index diet is predictive of increased body weight in adults and children.
Taken together, numerous aspects of ultra-processed products may override the biological
and behavioral regulators of food intake, causing food consumption to become dysregulated
from biological requirements. In susceptible individuals, these stimuli may lead to obesity or
disordered eating.
Future Directions
Given data showing that binge and loss of control eating episodes are often comprised of
highly palatable, energy-dense foods, an important next research step involves studying the
effects of ultra-processed food on BED or loss of control eating. Furthermore, more
generally, investigations are needed to elucidate the causal links between BED and obesity.
Key Reference
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Obesity-Related Consequences
State of Current Knowledge
There is a strong association of BED with obesity in cross-sectional studies. However, there
are few longitudinal studies, so that the nature of the causal relationships between BED and
obesity is uncertain. Specifically, it is unclear whether BED causes excessive weight gain
and obesity. However, among children and adolescents, loss of control of eating predicts
subsequent excessive weight gain. In addition, there is some evidence that childhood loss of
control eating and adult BED are associated with subsequent development of components of
the metabolic syndrome independent of potential mediating effects of obesity.
Future Directions
A major priority for future research is to conduct longitudinal studies to determine if the
development of BED or loss of control eating at different ages is predictive of subsequent
excessive weight gain and obesity, as well as obesity-related and other health outcomes. To
facilitate this goal and to link data on BED and loss of control eating to disease registries, it
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will be useful to include brief assessments of loss of control eating and other proxy measures
of BED in large cohort studies, assessments used by health maintenance organizations, and
surveys used in military screening.
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Animal/Basic
State of Current Knowledge
Animal models of binge eating have been developed in rodents. In these models, rodents are
exposed to cyclic caloric restriction and re-feeding to simulate dieting, and are exposed to
stress (e.g., foot shock or letting rat see and smell, but not taste, food). The binge eating that
appears in animal models has clinical human parallels in that large food intakes are greater
than those produced by hunger; persist despite punishment; can be triggered by stress or a
single “morsel” of palatable food; and are associated with biomarkers of stress, depression,
and anxiety.
The primary physiologic targets investigated in animal models have included stress
mechanisms (e.g., corticosterone, brain stress-hormone receptors); reward and craving
mechanisms (e.g., dopamine, opioids, glutamate, gamma amino butyric acid); and hunger
and satiety mechanisms (serotonin and the melanocortin system).
Different drug types work best on different animal models of BED, depending on the factors
used to develop these models. These results suggest that different etiologic factors may
affect the brain differently to express binge eating.
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A priority for future research is to refine drug testing to develop more targeted and
efficacious treatments. Animal models should be used to help identify genetic markers, the
biology of BED-relevant gene-environment interactions, and the biology discriminating risk
for BED associated with obesity versus BED not associated with obesity.
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Psychological Treatment
State of Current Knowledge
Psychological treatment for BED targets reducing binge eating, weight, and shape concerns,
and preventing excess weight gain and/or inducing modest weight loss. The psychotherapies
most evaluated in clinical trials include cognitive-behavioral therapy (CBT), interpersonal
psychotherapy (IPT), behavioral weight loss (BWL) and CBT self-help approaches
(CBTgsh). CBT is based on the restraint model, which proposes that decreasing dietary
restraint will improve attitudes toward eating, weight, and shape, which in turn, will
decrease binge eating. IPT proposes that by improving interpersonal functioning and self-
esteem, negative affect is decreased and, in turn, binge eating is reduced. CBT and IPT
produce marked and long-lasting impact on binge eating and associated psychopathology
and lead to modest, long-term weight loss in those who cease binge eating. CBT
demonstrates significant specificity of treatment effects compared to medication, supportive
psychotherapy, and BWL. As compared to medication, CBT may be especially relevant for
those BED patients with overvaluation of shape and weight on the outcomes of depression
and associated eating disorder psychopathology. IPT evidences high retention and treatment
acceptability, and is superior to CBTgsh for more severely ill patients; for example, those
presenting with high frequency of binge eating and compensatory behavior, high weight/
shape concern, negative affect, and distress and in patients with low self-esteem. BWL does
not specifically target binge eating, but may be more easily disseminated than CBT and IPT,
and increases restraint and induces modest weight loss in the short term. However, it is not
as effective as CBT or IPT with respect to remission of binge eating in the long term. Given
its cost-effectiveness, CBTgsh may be an optimal first-line treatment option, especially
when specialist care (e.g., CBT or IPT) is not available.
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Given that effective treatments exist for most individuals with BED, future research is
needed to bolster public health impact by improving access to empirically supported
treatments, by investigating how best to disseminate such treatments into the community.
Specifically, future research should examine best implementation methods for training
therapists and best methods for increasing scalability of these interventions. Another area
requiring study involves addressing the diverse needs of patients, particularly those who do
not respond to established treatments. Research is also needed that focuses on early
intervention. Finally, data on the cost effectiveness of early intervention and treatment are
needed.
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State of Current Knowledge
The underlying rationale for pharmacologic treatment is that biological factors influence
BED, and medications have been useful in the treatment in the treatment of conditions
commonly comorbid with BED, such as mood disorders, anxiety disorders, and substance
use disorders. Although as yet no specific targets identified for BED (or for its comorbid
conditions), potential targets include neurotransmitters (such as monoamines) and
medications targeting certain brain pathways, such as the reward circuit via dopamine
modulation.
Examining the results of clinical trials of pharmacologic treatment in BED, three
medications or classes of medications have been studied in two or more placebo-controlled
trials and therefore provide some basis for preliminary conclusions about efficacy. There
have been six studies of selective serotonin reuptake inhibitors (SSRIs), two studies of
sibutramine, and two studies of topiramate. All three of these groups produce clinically
meaningful reductions in frequency of binge eating relative to placebo in short-term trials,
and sibutramine and topiramate (but not SSRIs) also produce clinically meaningful
reductions in body weight. However, sibutramine has been withdrawn from the market and
topiramate is frequently associated with problematic cognitive effects, thus limiting its
clinical utility.
A number of medications have been studied in either a single-placebo controlled trial or in
an open-label case series. It is difficult to assess efficacy from these reports. However, none
of these medications has thus far shown extraordinary promise in terms of its combination of
efficacy and safety so that future development will likely seek to find other medications for
BED, rather than develop further these particular agents.
The medications used thus far in clinical studies have a large variety of potential
mechanisms of action in BED, including effects on neurotransmitters (serotonin,
norepinephrine, dopamine, glutamate, gamma-aminobutyric acid), effects that are
antiepileptic (e.g., topiramate, zonisamide and lamotrigine), and effects related potentially to
the reward pathway (e.g., dopamine).
Future Directions
Larger, more definitive trials command a high research priority to determine the efficacy
and safety of drug treatment for BED. Another priority for future research is to identify
better targets for drug intervention, including genetic factors, neural circuit abnormalities,
and mechanisms controlling food intake. Also, since no drug for treatment of BED is
approved for marketing in the US or other countries, a pathway for approval should be
developed that includes consensus about what constitute adequate demonstration of efficacy
and how to integrate the effects of treatment not only on binge eating, but also on body
weight, into the overall assessment of efficacy.
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Surgical Treatment
State of Current Knowledge
Currently, the three main procedures used for bariatric surgery are Roux-en-Y gastric
bypass, gastric banding, and sleeve gastrectomy. All induce loss of body weight, but the
gastric band is less effective than the other two procedures. The mechanisms involved
include restriction (all three), malabsorption (gastric bypass), and hormonal changes such as
effects on glucagon-like peptide 1 (GLP-1) and peptide YY3-36 (gastric bypass and sleeve
gastrectomy). In terms of the relationship of bariatric surgery to BED, the presence of BED
predicts less weight loss or more weight regain in some studies, but this is not a consistent
finding. However, the presence of loss of control eating post-surgery consistently predicts
less loss or greater weight regain.
Future Directions
A priority for future research is to develop pre- and post-surgical interventions to prevent the
emergence or reemergence of loss of control eating. Also of importance is elucidating the
mechanism whereby bariatric surgery suppresses binge eating and by which loss of control
eating emerges post-surgery. In particular, it is likely that these mechanisms involve
hormonal changes (in addition to other effects), and understanding these hormonal changes,
in turn, could help shed light on mechanisms related to loss of control eating. In this regard,
studies using the gastric sleeve may be useful, in that this procedure has no pouch, but does
induce hormonal changes.
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Relevance to Military Health and Readiness
State of Current Knowledge
Members of the military are likely at high-risk for BED. Although this hypothesis has not
been tested, the strict requirements for weight and fitness to which military personnel must
adhere result in a heightened external pressure for weight loss. It is proposed that this
pressure often leads to excessive dietary restraint and, in response individuals are led to
engage in binge eating. In addition, deployments as well as frequent relocations may
contribute to binge eating in response to stress. To date, only five studies of binge eating
have been conducted in military populations and most used of self-report questionnaires.
Notably, none specifically captured DSM-IV criteria for BED; rather research assessed for
EDNOS. Across studies, the prevalence estimates for binge eating have ranged from 10% –
35%, with higher estimates (upwards of 60%) for those not meeting their service weight
standards. However, there are no data on whether BED is accurately identified and
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diagnosed in military settings, and there is no research on treatment efficacy in military
populations. There are also no studies on the numbers of military members not deployable
due to BED, and no information on the frequency of fitness and weight “failures” among
individuals with the disorder. Although military members who receive effective treatment
for BED may be able to remain in service, personnel failing weight standards may be
separated from (no longer allowed to serve in) the military. Given the strong association
between BED and excess body weight, members who suffer from the disorder likely
struggle to meet the required weight and fitness regulations mandated by their service.
Therefore, members may be separated from the military due to their weight, rather than
receiving appropriate treatment for BED and remaining in service.
Future Directions
Given the dearth of data on BED and the military, the future research directions proposed
were relatively straightforward. Less straightforward, and beyond the scope of the
workshop, was a discussion of the barriers and challenges to conduct research in military
populations. Nevertheless, there was unanimous agreement that the primary next research
step includes determining the prevalence of BED in military populations and subpopulations
to elucidate not only the scope of the problem, but to understand if military members are at
greater risk for the disorder than civilian populations. Part of this effort should involve
examining whether one branch or service of the military is at greater risk for BED than
another. In addition, it should be determined how many of those individuals not meeting
weight or fitness standards are struggling with BED. Another important research direction
should involve determining whether treatment response to BED is similar to that observed in
civilian studies. Lastly, studies should be conducted to assess the impact of BED on both
military readiness and the financial burden on the Department of Defense.
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Personal and Societal Cost
State of Current Knowledge
There is clear personal cost to BED. Individuals with the disorder suffer from psychological
distress including isolation, stigmatization, and difficulties with interpersonal and family
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relationships. Despite some effective treatments for BED, it is often difficult for individuals
with the disorder to access care. Lack of knowledge, limited numbers of trained
professionals, and insufficient insurance coverage are among the reasons that individuals
with BED do not receive appropriate intervention. BED also incurs a cost to society. In
addition to poor social functioning with friends, family and co-workers, those with BED
have a higher prevalence of multiple health problems that often result in missed work, which
in turn impacts on individual businesses and the broader economy. Furthermore, healthcare
expenses incurred due to the associated physical problems also result in societal costs.
Future Directions
Raising awareness of BED and its associated costs is required. Individuals and organizations
need to be informed about how BED impacts society. This effort involves educating the
general public, mental health and allied health professionals, educators, payers, and policy-
makers. Another important next step includes increasing advocacy, education, fund-raising,
and outreach responsibility to national, regional, and local eating disorder, obesity and
provider organizations.
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Conclusion
With the inclusion of BED in the DSM-5, we face a new frontier of exciting and important
research opportunities. To date, investigators in the fields of eating disorders, obesity and
addictions have worked primarily independently. In a workshop including representatives
from many fields and from the NIH, overviews of the state of the field and future directions
for research were discussed. While the current report represents the proceedings from the
meeting, it is not comprehensive in terms of all potential directions for study, but rather
provides a foundation for the next generation of BED research.
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Appendix 1. Binge Eating Disorder: The Next Generation of Research Slide
Presentations
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